The HIT2 antibody is specific for human CD38, a 45 kD type II transmembrane glycoprotein expressed on thymocytes, activated T and B cells, and monocytes as well as other non-hematopoietic cells. CD38 is an ectoenzyme that functions to catalyze the synthesis and hydrolysis of cyclic ADP-ribose and is involved in cell signaling, regulating cell adhesion, and activation. Additionally, CD38 has been shown to be a prognostic marker for some leukemias and other diseases.
|Name||FITC Anti-Human CD38 (HIT2)|
|Technical Data Sheet||Download TDS|
|Alternative Names||Cyclic ADP-Ribose Hydrolase, ADP-Ribosyl Cyclase|
|Isotype||Mouse IgG1, kappa|
Dianzani U, and Malavasi F. 1995. Crit. Rev. Immunol. 15(2):167-200.
Mehta K, Shahid U, and Malavasi F. Oct. 1996. FASEB J. 10(12):1408-1417.
Ferrero E, and Malavas F. Feb. 1999. J. Jeukoc. Biol. 65(2):151-161.
Matrai Z. Feb. 2005. Hematology. 10(1):39-46.